NEC and Securonix Forge Strategic Alliance to Strengthen Advanced Cyber Defence Solutions

SINGAPORE, Feb. 20, 2024 /PRNewswire/ — NEC Asia Pacific (NEC APAC), the…

STAKE.COM NAMED BY UFC® AS OFFICIAL PARTNER IN THE PHILIPPINES

MANILA, Philippines, Feb. 20, 2024 /PRNewswire/ — UFC®, the world’s premier mixed…

STAKE.COM NAMED BY UFC® AS ITS OFFICIAL PARTNER IN MACAU

MACAU, Feb. 20, 2024 /PRNewswire/ — UFC®, the world’s premier mixed martial arts…

MANHATTAN ASSOCIATES AUSTRALIA RECOGNISED AS GREAT PLACE TO WORK

SYDNEY, Feb. 20, 2024 /PRNewswire/ — Manhattan Associates Inc. (NASDAQ: MANH) today…

Fasoo Rides the K-Security Wave Following the Success of K-Pop and K-Drama in Southeast Asia

SEOUL, South Korea, Feb. 20, 2024 /PRNewswire/ — Fasoo, a leader in…

Casio to Release G-SHOCK Collaboration Watches Featuring K-POP Girl Group, ITZY

TOKYO, Feb. 20, 2024 /PRNewswire/ — Casio Computer Co., Ltd. announced today…

Zühlke appoints Eric Cheung as CEO APAC & Member of the Group Executive Committee

SINGAPORE, Feb. 20, 2024 /PRNewswire/ — Zühlke announces the appointment of Eric Cheung…

Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA

ROCKVILLIE, MD. and SUZHOU, China, Feb. 20, 2024 /PRNewswire/ — Innovent Biologics,…